Literature DB >> 26891720

Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia.

K Konstantopoulos1, P Vogazianos1, T Doskas1.   

Abstract

The Montreal Cognitive Assessment (MoCA) is a brief cognitive instrument for the measurement of dementia. The aim of the present study is to provide normative data for the MoCA test in the Greek speaking population and to measure its validity in a clinical group of parkinsonian dementia participants. A total of 710 healthy Greek speaking participants and 19 parkinsonian dementia participants took part in the study. Both, the MoCA test and a neuropsychological test battery (digit span, semantic verbal fluency, phonemic verbal fluency, Color Trails Test) were administered to the normative and clinical samples. The test was found to correlate with all neuropsychological tests used in the test battery and it showed high discriminant validity (optimal screening cutoff point = 21, sensitivity = 0.82, specificity = 0.90) in the parkinsonian dementia participants. Further research is needed to use it in larger clinical samples and in different neurological diseases.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Assessment; Dementia; Movement disorders; Norms/normative studies; Parkinson's disease

Mesh:

Year:  2016        PMID: 26891720     DOI: 10.1093/arclin/acw002

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  19 in total

1.  Aging and the Perception of Affective and Linguistic Prosody.

Authors:  Maria Martzoukou; Grigorios Nasios; Mary H Kosmidis; Despina Papadopoulou
Journal:  J Psycholinguist Res       Date:  2022-04-20

2.  The performance of patients with Parkinson's disease on the Face-Name Associative Memory Examination.

Authors:  Constantinos Kormas; Ioannis Zalonis; Ioannis Evdokimidis; Constantin Potagas
Journal:  Neurol Sci       Date:  2018-09-12       Impact factor: 3.307

3.  Influence of Social and Demographic Factors on the Montreal Cognitive Assessment (MoCA) Test in Rural Population of North-Eastern Greece.

Authors:  Anna Tsiakiri; Konstantinos Vadikolias; Grigorios Tripsianis; Pinelopi Vlotinou; Aspasia Serdari; Aikaterini Terzoudi; Ioannis Heliopoulos
Journal:  Geriatrics (Basel)       Date:  2021-04-17

4.  Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease.

Authors:  Marta Statucka; Kirsten Cherian; Alfonso Fasano; Renato P Munhoz; Melanie Cohn
Journal:  Mov Disord Clin Pract       Date:  2021-05-27

5.  The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.

Authors:  Emma Borland; Katarina Nägga; Peter M Nilsson; Lennart Minthon; Erik D Nilsson; Sebastian Palmqvist
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Clinical validation of a public health policy-making platform for hearing loss (EVOTION): protocol for a big data study.

Authors:  Giorgos Dritsakis; Dimitris Kikidis; Nina Koloutsou; Louisa Murdin; Athanasios Bibas; Katherine Ploumidou; Ariane Laplante-Lévesque; Niels Henrik Pontoppidan; Doris-Eva Bamiou
Journal:  BMJ Open       Date:  2018-02-15       Impact factor: 2.692

7.  The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples.

Authors:  Alessandra E Thomann; Nicolai Goettel; Raphael J Monsch; Manfred Berres; Thomas Jahn; Luzius A Steiner; Andreas U Monsch
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Differences in the Presentation and Progression of Parkinson's Disease by Sex.

Authors:  Hirotaka Iwaki; Cornelis Blauwendraat; Hampton L Leonard; Mary B Makarious; Jonggeol J Kim; Ganqiang Liu; Jodi Maple-Grødem; Jean-Christophe Corvol; Lasse Pihlstrøm; Marlies van Nimwegen; Luba Smolensky; Ninad Amondikar; Samantha J Hutten; Mark Frasier; Khanh-Dung H Nguyen; Jacqueline Rick; Shirley Eberly; Faraz Faghri; Peggy Auinger; Kirsten M Scott; Ruwani Wijeyekoon; Vivianna M Van Deerlin; Dena G Hernandez; Raphael J Gibbs; Aaron G Day-Williams; Alexis Brice; Guido Alves; Alastair J Noyce; Ole-Bjørn Tysnes; Jonathan R Evans; David P Breen; Karol Estrada; Claire E Wegel; Fabrice Danjou; David K Simon; Ole A Andreassen; Bernard Ravina; Mathias Toft; Peter Heutink; Bastiaan R Bloem; Daniel Weintraub; Roger A Barker; Caroline H Williams-Gray; Bart P van de Warrenburg; Jacobus J Van Hilten; Clemens R Scherzer; Andrew B Singleton; Mike A Nalls
Journal:  Mov Disord       Date:  2020-10-01       Impact factor: 9.698

9.  The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease.

Authors:  Ji In Kim; Mun Kyung Sunwoo; Young H Sohn; Phil Hyu Lee; Jin Y Hong
Journal:  J Mov Disord       Date:  2016-09-21

10.  Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease.

Authors:  Vitor Tumas; Vanderci Borges; Henrique Ballalai-Ferraz; Cyrus P Zabetian; Ignácio F Mata; Manuelina M C Brito; Maria Paula Foss; Nathalia Novaretti; Bruno Lopes Santos-Lobato
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.